Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2014-05-15 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2014-05-15 English
PRIMARY DOCUMENT
Director's Dealing
2014-05-15 English
PRIMARY DOCUMENT
Director's Dealing
2014-05-15 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The content focuses on the approval and details of the 2014 Management Incentive Plan, including bonus structures and performance targets for senior management. It discusses compensatory arrangements for officers and directors, which aligns with announcements about management compensation plans. There is no detailed financial report or earnings data, nor is it a full annual or quarterly report. The document is not a proxy statement or remuneration report but rather an announcement of management incentive plan terms and related compensatory arrangements. According to the filing definitions, announcements about changes or arrangements related to senior management compensation fall under Board/Management Information (MANG). The document length (7124 characters) and detailed description of the incentive plan support this classification rather than a brief announcement or a full remuneration report.
2014-05-15 English
10-Q
Interim / Quarterly Report Q1 2014
2014-05-08 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2014, by OraSure Technologies, Inc. It announces the company's consolidated financial results for the quarter ended March 31, 2014, and provides financial guidance for the next quarter. It includes a press release (Exhibit 99.1) and prepared remarks for a conference call (Exhibit 99.2). The content corresponds to an initial announcement of quarterly financial results with key highlights and guidance, which fits the definition of an Earnings Release (ER). The presence of a conference call transcript excerpt supports this classification but the main document is the earnings announcement. The document length is about 5088 characters, which is sufficient for an earnings release. Therefore, the filing type is Earnings Release (ER) with high confidence.
2014-05-07 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.